# OnCo record al-273 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/al-273/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "al-273" ;
  schema:name "AL-273"@en ;
  schema:description "AL-273 is an experimental small molecule from Alaw Therapeutics, at a stage the company does not state for EGFR-driven tumours."@en ;
  schema:url <https://onco.cc/drugs/al-273/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.alawtx.com/pipeline> ;
  onco:tag "pipeline" ;
  onco:modality "Small molecule" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:companies <https://onco.cc/companies/alaw-therapeutics/> .